Archive: 2026/01 - Page 2

Real-world evidence from patient registries and claims data is now critical for monitoring drug safety after approval. Learn how these sources detect hidden risks, their strengths and limits, and how regulators use them to protect patients.

Medication adherence apps use smartphone reminders, tracking, and education to help people take their pills on time. Proven effective in clinical studies, they outperform pill organizers and SMS alerts-with most working for free.

Heart disease risk factors include age, family history, smoking, high blood pressure, and cholesterol. Learn which ones you can't change and which you can control to protect your heart before it's too late.

Learn how to manage sleep apnea, reflux, and positioning during pregnancy to improve rest and reduce risks like preeclampsia and gestational diabetes. Evidence-based tips for CPAP use, pregnancy pillows, and safe reflux relief.

Learn the proven options for preserving fertility before chemotherapy, from egg freezing to ovarian tissue cryopreservation. Understand timing, success rates, costs, and emotional impact.

Learn how to track symptoms after a drug or device safety alert. Step-by-step guide on what to watch for, when to report, and how to use tools safely to protect your health.

When drugs are unavailable due to shortages or allergies, compounding pharmacies create custom medications tailored to individual needs-offering solutions like allergen-free formulas, flavored liquids, and precise dosages that big manufacturers can't provide.

Tentative approval from the FDA means a generic drug is scientifically ready-but legal, manufacturing, or market barriers often delay its launch for years. Here’s why affordable alternatives still take so long to reach patients.

Biosimilars are complex biologic drugs that can't be copied like generic pills. Their production requires precise control over living cells, glycosylation, and scaling - making them far harder and costlier to manufacture than traditional generics.